Litcius/Paper detail

Immunotherapy in advanced Non-Small Cell Lung Cancer patients with poor performance status: The role of clinical-pathological variables and inflammatory biomarkers

Riccardo Lobefaro, Giuseppe Viscardi, Raimondo Di Liello, Giacomo Massa, Maria Lucia Iacovino, Francesca Sparano, Carminia Maria Della Corte, Roberto Ferrara, Diego Signorelli, Claudia Proto, Arsela Prelaj, Giulia Galli, Alessandro De Toma, Marta Brambilla, Monica Ganzinelli, B. Trevisan, Fortunato Ciardiello, Filippo de Braud, Floriana Morgillo, Marina Chiara Garassino, Giuseppe Lo Russo

2020Lung Cancer39 citationsDOI

Topics & Concepts

MedicineInternal medicineLung cancerHazard ratioImmunotherapyPerformance statusPathologicalProportional hazards modelUnivariate analysisMultivariate analysisOncologyGastroenterologyClinical trialCancerSurvival analysisConfidence intervalCancer Immunotherapy and BiomarkersInflammatory Biomarkers in Disease PrognosisLung Cancer Research Studies
Immunotherapy in advanced Non-Small Cell Lung Cancer patients with poor performance status: The role of clinical-pathological variables and inflammatory biomarkers | Litcius